vs
Side-by-side financial comparison of FOCUS UNIVERSAL INC. (FCUV) and ORGANIGRAM GLOBAL INC. (OGI). Click either name above to swap in a different company.
ORGANIGRAM GLOBAL INC. is the larger business by last-quarter revenue ($39.6K vs $35.3K, roughly 1.1× FOCUS UNIVERSAL INC.). ORGANIGRAM GLOBAL INC. runs the higher net margin — -192.9% vs -4261.7%, a 4068.8% gap on every dollar of revenue. ORGANIGRAM GLOBAL INC. produced more free cash flow last quarter ($-19.9K vs $-1.4M).
Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.
Organigram Global Inc. is a leading Canadian producer of high-quality recreational and medical cannabis products. It offers a diverse portfolio of dried flower, edibles, vape products and pre-rolls, primarily serving the domestic Canadian market while expanding operations in select international markets including parts of Europe.
FCUV vs OGI — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2022
| Metric | | |
|---|---|---|
| Revenue | $35.3K | $39.6K |
| Net Profit | $-1.5M | $-76.5K |
| Gross Margin | -35.1% | — |
| Operating Margin | -4366.7% | -128.4% |
| Net Margin | -4261.7% | -192.9% |
| Revenue YoY | 214.5% | — |
| Net Profit YoY | -10.3% | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | $35.3K | — | ||
| Q1 25 | $190.3K | — | ||
| Q4 24 | $133.2K | — | ||
| Q3 24 | $74.2K | — | ||
| Q1 24 | $179.5K | — | ||
| Q4 23 | $-82.8K | — | ||
| Q3 23 | $71.9K | — | ||
| Q2 23 | $215.4K | — |
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-1.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.4M | — | ||
| Q1 24 | $-1.3M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-968.0K | — | ||
| Q2 23 | $-1.0M | — |
| Q2 25 | -35.1% | — | ||
| Q1 25 | 16.1% | — | ||
| Q4 24 | -95.4% | — | ||
| Q3 24 | 42.7% | — | ||
| Q1 24 | 50.3% | — | ||
| Q4 23 | 107.8% | — | ||
| Q3 23 | 38.2% | — | ||
| Q2 23 | 30.7% | — |
| Q2 25 | -4366.7% | — | ||
| Q1 25 | -668.3% | — | ||
| Q4 24 | -1507.4% | — | ||
| Q3 24 | -2353.8% | — | ||
| Q1 24 | -676.3% | — | ||
| Q4 23 | 1869.7% | — | ||
| Q3 23 | -1518.7% | — | ||
| Q2 23 | -497.5% | — |
| Q2 25 | -4261.7% | — | ||
| Q1 25 | -657.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1942.9% | — | ||
| Q1 24 | -732.9% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -1347.2% | — | ||
| Q2 23 | -472.7% | — |
| Q2 25 | — | — | ||
| Q1 25 | $-0.17 | — | ||
| Q4 24 | $-4.57 | — | ||
| Q3 24 | $0.02 | — | ||
| Q1 24 | $-0.20 | — | ||
| Q4 23 | $-0.73 | — | ||
| Q3 23 | $-0.01 | — | ||
| Q2 23 | $-0.02 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $845.6K | — |
| Total Assets | $1.7M | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | $1.2M | — | ||
| Q1 25 | $2.2M | — | ||
| Q4 24 | $3.6M | — | ||
| Q3 24 | $5.4M | — | ||
| Q1 24 | $114.1K | — | ||
| Q4 23 | $465.0K | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q2 25 | $845.6K | — | ||
| Q1 25 | $1.9M | — | ||
| Q4 24 | $3.2M | — | ||
| Q3 24 | $5.4M | — | ||
| Q1 24 | $2.4M | — | ||
| Q4 23 | $3.5M | — | ||
| Q3 23 | $4.9M | — | ||
| Q2 23 | $5.6M | — |
| Q2 25 | $1.7M | — | ||
| Q1 25 | $2.7M | — | ||
| Q4 24 | $4.1M | — | ||
| Q3 24 | $6.2M | — | ||
| Q1 24 | $5.0M | — | ||
| Q4 23 | $5.3M | — | ||
| Q3 23 | $6.4M | — | ||
| Q2 23 | $6.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $-15.2K |
| Free Cash FlowOCF − Capex | $-1.4M | $-19.9K |
| FCF MarginFCF / Revenue | -4047.4% | -50.2% |
| Capex IntensityCapex / Revenue | 4.8% | 11.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | $-1.4M | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-997.9K | — | ||
| Q3 24 | $-1.9M | — | ||
| Q1 24 | $-892.1K | — | ||
| Q4 23 | $-925.2K | — | ||
| Q3 23 | $-996.8K | — | ||
| Q2 23 | $-768.2K | — |
| Q2 25 | $-1.4M | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-1.0M | — | ||
| Q3 24 | $-1.9M | — | ||
| Q1 24 | $-897.1K | — | ||
| Q4 23 | $-925.5K | — | ||
| Q3 23 | $-999.9K | — | ||
| Q2 23 | $-775.5K | — |
| Q2 25 | -4047.4% | — | ||
| Q1 25 | -653.6% | — | ||
| Q4 24 | -753.3% | — | ||
| Q3 24 | -2614.6% | — | ||
| Q1 24 | -499.8% | — | ||
| Q4 23 | 1117.8% | — | ||
| Q3 23 | -1391.6% | — | ||
| Q2 23 | -360.0% | — |
| Q2 25 | 4.8% | — | ||
| Q1 25 | 12.3% | — | ||
| Q4 24 | 4.1% | — | ||
| Q3 24 | 4.7% | — | ||
| Q1 24 | 2.8% | — | ||
| Q4 23 | -0.4% | — | ||
| Q3 23 | 4.3% | — | ||
| Q2 23 | 3.4% | — |
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.34× | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FCUV
Segment breakdown not available.
OGI
| Unrealized gain on changes in fair value of biological assets (Note 7) | $20.1K | 51% |
| Other | $19.6K | 49% |
